Limatoc, Ailene C.

HRN: 26-30-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
CEFTRIAXONE 1G (VIAL)
11/29/2024
12/06/2024
IVT
2g
OD
CAP
Waiting Final Action 
11/29/2024
CLARITHROMYCIN 500MG (CAP)
11/29/2024
12/06/2024
ORAL
500mg
BID
H Pylori
Waiting Final Action 
11/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/29/2024
12/06/2024
IVT
500mg
BID
H Pylori
Waiting Final Action 
12/05/2024
CEFTAZIDIME 1GM (VIAL)
12/05/2024
12/12/2024
IV
2 Grams
Q 8hrs
Cap MR
Waiting Final Action 
12/07/2024
LEVOFLOXACIN 500MG (TAB)
12/07/2024
12/13/2024
PO
500mg
OD
Cap-mr
Waiting Final Action 
12/15/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/15/2024
12/21/2024
IV
1.5
Q6
CAP
Waiting Final Action 
12/18/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/18/2024
12/25/2024
IV
4.5g
Q8H
CAP
Waiting Final Action 
12/19/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/19/2024
12/25/2024
IV
500
OD
CAP
Waiting Final Action 
12/21/2024
FLUCONAZOLE 150MG (CAP)
12/21/2024
01/04/2025
ORAL
150mg
OD
Yeast Infection
Waiting Final Action 
12/27/2024
CEFIXIME 200MG (CAP)
12/27/2024
01/02/2025
PO
200mg
BID
Cap
Waiting Final Action 
12/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/30/2024
01/06/2025
IVTT
500 Mg
Q6
Cap-HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: